ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
会议论文

Sitravatinib plus tislelizumab in patients with anti-PD-(L)1 refractory/resistant metastatic non-small cell lung cancer (NSCLC)

Gao, B.; Ma, Z.; Yu, X.; Huang, D.; Zhao, J.; Day, D.; Body, A. L.; Zhou, Q.; Chu, Q.; Pan, H.; Cui, J.; Li, H.; Sun, J.; Zhang, J.; Fei, C.; Wu, Y-L.广东省人民医院; 华中科技大学; 吉林大学; 浙江大学; 郑州大学; 中国科学院研究生院
ESMO Targeted Anticancer Therapies Congress (TAT)2022-3DOI: 10.1016/j.annonc.2022.01.063
2被引10阅读
引用收藏
分享
相关
加载中…
  • Sitravatinib plus tislelizumab in patients with metastatic non-small cell lung cancer (NSCLC)
    Zhou, Q.; Yu, X.; Gao, B.; Ma, Z.; Chu, Q.; Huang, D.; Zhao, J.; Day, D.; Body, A. L.; Pan, H.; Cui, J.; Li, H.; Sun, J.; Zhang, J.; Fei, C.; Wu, Y-L.ESMO Targeted Anticancer Therapies Congress (TAT), ELECTR NETWORK, 2022-03-07 To 2022-03-08.
  • Safety, tolerability, and preliminary antitumor activity of sitravatinib plus tislelizumab (TIS) in patients (pts) with unresectable locally advanced or metastatic gastric cancer/gastroesophageal junction cancer (GC/GEJC)
    Chen, Zhendong; Bai, Yuxian; Zhang, Tao; Ying, Jieer; Lin, Xiaoyan; Yang, Liu; Wang, Jun; Zhang, Juan; Yu, Fan; Fei, Cong; Huang, Ruiqi; Li, JinASCO Gastrointestinal Cancers Symposium, San Francisco, CA, 2022-01-20 To 2022-01-22.被引 1
  • Sintilimab versus pembrolizumab in monotherapy or combination with chemotherapy as first-line therapy for advanced non-small cell lung cancer: Results from phase 2, randomized clinical trial (CTONG1901).
    Liu, Si-Yang Maggie; Zhou, Qing; Yan, Hong-Hong; Bin, Gan; Yang, Ming-Yi; Deng, Jia-Yi; Tu, Hai-Yan; Zhang, Xuchao; Su, Jian; Yang, Jinji; Wu, Yi-LongAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 2022-06-03 To 2022-06-07.被引 6
查看全部 →

会议信息

会议名称
ESMO Targeted Anticancer Therapies Congress (TAT)
会议日期
2022-03-07 至 2022-03-08
论文集名
ANNALS OF ONCOLOGY
发表日期
2022-03
起止页码
S1-S1
DOI
10.1016/j.annonc.2022.01.063
资助标注
BeiGene, Ltd.
收录
ISTP · SCIE

作者

  • G

    Gao, B. (第一作者)

  • M

    Ma, Z.

    zhengzhou univ

查看全部 16 位作者收起作者
  • Y

    Yu, X.

    zhejiang canc hosp · univ chinese acad sci

  • H

    Huang, D.

    tianjin med univ canc inst & hosp

  • Z

    Zhao, J.

    peking univ canc hosp & inst

  • D

    Day, D.

  • B

    Body, A. L.

  • Z

    Zhou, Q.

    guangdong gen hosp

  • C

    Chu, Q.

    huazhong univ sci & technol

  • P

    Pan, H.

    zhejiang univ

  • C

    Cui, J.

    jilin univ

  • L

    Li, H.

  • S

    Sun, J.

  • Z

    Zhang, J.

  • F

    Fei, C.

  • W

    Wu, Y-L.

    guangdong prov peoples hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417